Gene Query: COX18

Dataset Description Geneva Score
RIG-I and MDA5 fRIP during KSHV lytic reactivation 22.88
Mitochondrial dsRNA triggers antiviral signalling in humans 9.91
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 6.77
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 6.31
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 6.31
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 5.92
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 5.63
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 5.51
Hijacking of stress response machinery by oncogenes in acute leukaemia 5.51
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 5.35
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 5.35
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 5.18
T47D RNA-seq and ChrRNA-seq data 5.18
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 4.86
HEXIM1 is induced by DHODH inhibition to suppress melanoma 4.86
CD95/Fas ligand mRNA is toxic to cells 4.67
CROP-Seq in Primary Human T Cells 4.64
Comparison of microRNA Profiling Platforms 4.52
Comparison of microRNA Profiling Platforms (HTS) 4.52
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 4.38
4sU-seq of HFF exposed to salt and heat stress 4.26
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 4.21
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 4.21
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 4.2
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 4.1
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 4.02
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 4.02
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 4.01
HNRNPL and its RNA Targets in Prostate Cancer 3.91
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 3.91
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 3.87
Dtx3L and Androgen Signaling in Prostate Cancer 3.86
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 3.76
R430: A potent inbibitor of DNA and RNA viruses 3.73
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 3.56
Human neutrophil genome during PMA- and E. coli encounter-induced activation 3.52
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 3.52
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 3.35
RNA polymerase in pre-B-ALL cell lines 3.32
Role for citron kinase in prostate cancer growth 3.32
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 3.2
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 3.19
Integrating single-cell transcriptomic data across different conditions, technologies, and species 3.14
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 3.12
RNA sequencing of matched nephrectomy samples [RNA-seq] 3.12
Global transcriptome analysis of HAP1 cells 3.12
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 3.11
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 3.09
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 3.07
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 2.99
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 2.99
Gene expression changes after LOC550643 silencing 2.95
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 2.9
Lysine benzoylation is a novel histone mark 2.9
Lysine benzoylation is a novel histone mark [RNA-seq] 2.9
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 2.85
HNRNPM-regulated splicing dependencies in prostate cancer 2.85
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 2.8
Peptidomimetic blockade of MYB in acute myeloid leukemia 2.8
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 2.78
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 2.75
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 2.73
Transcriptional landscape changes during human embryonic stem cell derivation 2.66
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 2.59
Oncogenic MYC induces a dependency on the spliceosome in human cancer 2.57
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 2.54
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 2.52
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 2.52
Lipid degradation promotes prostate cancer cell survival 2.48
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 2.44
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 2.43
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 2.43
HNF1A deficiency impairs β-cell fate, granule maturation and function 2.43
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 2.39
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 2.38
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 2.35
Ribosomal footprinting of MDA-Parental and MDA-LM2 2.35
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 2.34
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 2.31
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 2.29
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 2.29
Ribosomal footprinting of CN34-Parental and CN34-LM1a 2.28
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 2.28
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 2.26
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 2.22
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 2.18
MeRIP-seq for heat shock in B-cell lymphoma cells 2.17
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 2.14
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 2.11
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 2.09
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 2.08
Capturing the Interactome of Newly Transcribed RNA 2.08
Capturing the Interactome of Newly Transcribed RNA (RICK) 2.08
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 2.06
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 2.01
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 1.98
N6-methyladenine DNA Modification in Glioblastoma 1.98
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 1.97
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 1.97
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 1.93
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 1.91
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 1.89
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 1.86
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 1.86
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 1.84
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 1.82
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 1.82
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 1.8
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 1.79
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 1.78
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 1.76
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 1.76
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 1.74
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 1.74
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 1.73
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 1.73
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 1.73
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 1.72
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 1.7
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 1.7
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 1.69
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 1.68
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 1.66
Gene expression in GBM with Cav3.2 inhibition 1.65
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 1.64
Modulation of nonsense-mediated decay by rapamycin 1.63
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 1.62
Transcriptome of U251 cells overexpression complement component 7 1.59
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 1.56
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 1.56
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 1.56
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 1.56
circRNA-sequencing 1.55
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 1.55
MYC dependent mRNA translation shapes gene expression and cell biology 1.55
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 1.55
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 1.55
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 1.54
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 1.53
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 1.53
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 1.51
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 1.49
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 1.49
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 1.49
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 1.48
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 1.48
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 1.48
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 1.48
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 1.45
AR-independent prostate cancer is sustained through FGF signaling 1.45
HEK293 TFAM Knockout Expression Study 1.44
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 1.44
Overexpression of NFIB and YBX1 in MCF-7 cells 1.43
RNA-seq of YB5 cells treated with Proscillaridin A 1.43
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 1.43
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 1.43
Mapping interactions for the TNIP2 hub protein 1.42
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 1.42
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 1.41
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 1.4
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 1.4
Identification of long noncoding RNAs regulated by p53 1.4
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 1.39
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 1.39
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 1.39
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 1.37
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 1.36
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 1.35
TT-Seq captures the human transient transcriptome 1.35
CDK4/6 inhibitor resistance in prostate cancer 1.35
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 1.34
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 1.32
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 1.32
RNA-seq of Single-Cell Genotyping of Transcriptomes 1.32
Single-Cell Genotyping of Transcriptomes 1.32
MicroRNA-125a-5p overexpression in human macrophages 1.32
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 1.31
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 1.3
RNA expression analysis upon JMJD1C depletion 1.3
Genome-wide mapping of TEL-AML1 targets in acute leukemia 1.3
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 1.3
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 1.3
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 1.3
Tracking distinct RNA populations using efficient and reversible covalent chemistry 1.29
Effect of PBK knockdown on C4-2 cell transcriptome 1.29
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 1.28
Effect of CHKA knockdown on C4-2 cell transcriptome 1.28
DRB/GRO-Seq -/+ UV 1.27
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 1.26
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 1.26
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 1.24
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 1.24
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 1.24
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 1.24
Global analysis of enhancer targets: Mosaic-seq 1.22
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 1.22
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 1.2
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 1.2
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 1.19
Genome-wide discovery of human splicing branchpoints 1.18
nELAVL HITS-CLIP in Alzheimer's Disease patients 1.15
RNA-Seq with and without RNase treatment in PCa cell lines 1.14
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 1.14
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 1.13
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 1.13
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 1.13
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 1.13
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 1.13
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 1.13
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 1.13
Identification of HOXB13 target genes responsive to BET inhibitors 1.13
Chromatin landscape of human visceral and subcutaneous adipocytes 1.12
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 1.12
An optimization system for isolating and sequencing of single human colon cancer cells 1.11
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 1.11
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 1.1
Global transcriptome analysis of WT versus HEB-/- hESCs 1.09
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 1.09
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 1.09
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 1.09
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 1.08
RNA-seq of naive and primed ES cells (NHSM) 1.08
Generating Patterned Kidney Organoids for Studying Development and Diseases 1.08
Transcriptome profiling of Normal and Cancerous Prostate Cells 1.08
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 1.07
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 1.07
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 1.07
RNA m5C Methylation in breast cancer using MeRIP-Seq 1.07
Transcriptome analysis of Zika infected neural stem cells 1.06
Zika infected neural stem cells 1.06
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 1.06
Gene expression analysis of breast cancer cell-lines 1.06
Gene expression and genome-wide location analysis of breast cancer cell-lines 1.06
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 1.05
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 1.04
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 1.03
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 1.02
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 1.02
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 1.02
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 1.01
A transcriptome-wide divergence in protein translation scales with LIN28B expression 1.01
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 1.0
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 0.98
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 0.98
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 0.97
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 0.97
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 0.97
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 0.96
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 0.95
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 0.95
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 0.93
Primate transcript and protein expression levels evolve under compensatory selection pressures 0.93
Overexpression and knockdown experiment for circCSNK1G3 0.93
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 0.92
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 0.92
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.91
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 0.91
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 0.91
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 0.91
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 0.91
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.9
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 0.89
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 0.89
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 0.88
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 0.88
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 0.88
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 0.86
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 0.86
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 0.85
Reassessment of Exosome Composition 0.85
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 0.85
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 0.84
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 0.84
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 0.81
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 0.8
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 0.8
Transcriptional effect of ETV1 knockdown in melanoma cells 0.77
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.77
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 0.77
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 0.75
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  0.75
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.75
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.75
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.75
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 0.74
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 0.74
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 0.74
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 0.73
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.72
Functional significance of the HIV-1 Tat signature amino acid residues 0.72
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 0.71
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 0.69
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 0.69
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 0.68
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 0.68
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 0.68
Downregulation of DDX5/DDX17 and REST 0.68
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 0.68
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 0.67
RNA-Seq from human ILC transitional populations 0.67
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 0.67
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 0.67
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 0.67
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 0.67
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 0.67
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 0.66
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 0.66
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 0.65
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 0.65
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 0.64
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 0.64
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 0.64
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 0.64
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 0.64
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 0.63
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 0.63
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 0.63
Tracing Enhancer Networks using Epigenetic Traits (TENET) 0.62
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 0.61
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 0.61
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 0.6
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.59
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.59
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 0.59
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 0.59
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 0.58
The cohesin release factor WAPL restricts chromatin loop extension. 0.58
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 0.57
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 0.57
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 0.56
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 0.56
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 0.56
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 0.56
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.55
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 0.55
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 0.55
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 0.55
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 0.54
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 0.54
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 0.54
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 0.52
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 0.51
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 0.51
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 0.51
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 0.5
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 0.5
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 0.5
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.5
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.5
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 0.49
Oncogenic roles of ARID5B in T-ALL 0.49
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.49
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 0.49
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.48
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 0.47
Molecular analysis of renal cell carcinoma with unclassfied histology 0.46
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 0.46
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 0.46
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 0.46
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 0.46
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 0.45
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 0.44
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 0.43
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 0.43
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 0.43
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.43
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 0.41
Triple vectors expand AAV transfer capacity in the retina 0.4
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.4
Epigenetic reprogramming of melanoma cells by vitamin C treatment 0.4
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.39
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.39
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.38
RNA-Seq and expression data from human adipose tissue 0.38
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 0.38
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 0.38
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 0.37
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 0.36
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 0.36
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 0.36
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 0.35
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 0.35
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.34
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 0.33
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 0.33
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 0.33
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.32
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 0.32
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 0.32
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 0.31
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.31
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 0.31
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 0.31
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.3
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.3
An integrative analysis of non-coding regulatory DNA variations associated with autism 0.3
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 0.29
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 0.29
O-glcnAc reprograms cellular energetics 0.29
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 0.29
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 0.29
High-resolution comparative analysis of great ape genomes 0.29
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 0.28
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 0.28
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 0.28
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 0.28
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 0.28
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 0.27
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 0.26
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.26
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 0.26
Myc activation coordinates gene transcription and protein translation responses 0.26
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 0.25
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.25
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 0.25
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 0.25
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.24
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 0.24
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 0.24
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 0.24
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 0.23
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 0.23
Identification of global XBP1s target gene expression in human prostate cancer cells 0.23
Transcriptional profiling of microglia; current state of the art and future perspectives 0.23
Microglia innatly develop within cerebral organoids 0.22
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.22
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 0.22
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.22
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 0.21
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 0.21
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.21
siRNA-mediated knockdown 0.21
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.21
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 0.21
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 0.2
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 0.19
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 0.19
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 0.19
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 0.19
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 0.19
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 0.19
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 0.19
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.18
Interphase condensins regulate ligand-depedent enhancer activation 0.18
K562 polyA RNA-Seq 0.18
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 0.17
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 0.17
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.17
RNA-seq of MDA-MB-231 cells with TET1 knockout 0.17
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 0.16
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.16
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.16
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.15
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.15
The transcriptomic landscape of MAIT cell development in the thymus (C006 RNAseq data set) 0.15
Loss of CREBBP results in gene expression repression in lymphoma cells 0.14
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 0.14
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.14
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 0.14
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 0.14
Role of FGFR1 in neuronal devlopment 0.14
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.14
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.14
Genome-wide Analysis of Chromatin Interactions in Human Cells 0.14
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 0.14
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 0.14
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 0.13
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 0.12
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 0.12
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 0.11
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.1
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 0.1
Epigenomic conservation of transposable element silencing [RNA-seq] 0.1
Epigenomic conservation of transposable element silencing 0.1
Metastasis in triple-negative breast cancer 0.09
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 0.09
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 0.09
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 0.08
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 0.08
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 0.07
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 0.07
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 0.07
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 0.05
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.05
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.04
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 0.04
Next generation sequencing of small RNAs isolated from exosomes in human semen 0.04
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.03
Human Tfh cell RNA bulk sequencing 0.03
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.03
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.03
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 0.02
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 0.02
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.02
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.02
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 0.01
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 0.01
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.0
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.0
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation